NIJ FY24 Invited to Apply - Adolescent Brain Cognitive Development: Social Development Sub-study (ABCD-SD)
ID: 355351Type: Posted
Overview

Buyer

National Institute of Justice (USDOJ-OJP-NIJ)

Award Range

$0 - $2M

Eligible Applicants

Others

Funding Category

Science and Technology and other Research and Development

Funding Instrument

Grant

Opportunity Category

Continuation

Cost Sharing or Matching Requirement

Yes

Original Source

https://grants.gov/search-results-detail/355351

Additional Information

https://nij.ojp.gov/funding/o-nij-2024-172213.pdf
Timeline
    Description

    The National Institute of Justice (NIJ) is inviting applications for the Adolescent Brain Cognitive Development: Social Development Sub-study (ABCD-SD) grant, aimed at funding a sub-study that will assess measures of delinquency and victimization across five sites of the ABCD Study, which is supported by the National Institute on Drug Abuse (NIDA). Eligible applicants must have received an official invitation letter from NIJ to apply, emphasizing the targeted nature of this funding opportunity. The total estimated program funding is $1.8 million, with a single award anticipated, and applications must be submitted by August 2, 2024. For further assistance, applicants can contact Kaitlyn Sill at Kaitlyn.Sill@usdoj.gov or reach out to the OJP Response Center at 800-851-3420.

    Point(s) of Contact
    Kaitlyn.Sill@usdoj.gov
    Files
    No associated files provided.
    Similar Opportunities
    NIH Brain Development Cohorts (NBDC) Biospecimen Access (X01 Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity for access to biospecimens from the Adolescent Brain Cognitive Development (ABCD) Study, the largest longitudinal study of child health in the United States. This initiative, titled NIH Brain Development Cohorts (NBDC) Biospecimen Access, allows researchers to utilize biological samples such as blood, saliva, and hair to investigate the effects of environmental and biological factors on adolescent brain development and health. The program does not provide direct funding for research costs; applicants must secure their own funding and can apply for specific samples to enhance scientific understanding of adolescent health over a maximum project period of three years. Interested applicants can find more information and submit inquiries via the NIH Grants Information email at grantsinfo@nih.gov, with applications due by May 5, 2026.
    NIJ FY24 Evaluation of BJA Byrne State Crisis Intervention Program (SCIP): Scan of Practices and Evaluability Assessments
    Active
    National Institute of Justice
    The National Institute of Justice (NIJ) is inviting proposals for the evaluation of the Bureau of Justice Assistance (BJA) Byrne State Crisis Intervention Program (SCIP) through a cooperative agreement. The objective is to examine programs funded by BJA under SCIP for Fiscal Years 2022-2024, focusing on practices related to extreme risk protection orders, court responses to individuals in crisis, community-based services, and law enforcement crisis intervention initiatives. This funding opportunity, with an estimated total program funding of $6.6 million and an award ceiling of $1.5 million per award, aims to support research in two categories: a scan of practices and evaluability assessments of the funded programs. Interested applicants must submit their proposals by November 19, 2024, and can contact the OJP Response Center at grants@ncjrs.gov for assistance.
    Accelerating the Pace of Child Health Research Using Existing Data from the Adolescent Brain Cognitive Development (ABCD) Study (R21-Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "Accelerating the Pace of Child Health Research Using Existing Data from the Adolescent Brain Cognitive Development (ABCD) Study," aimed at enhancing child health research through the analysis of existing data. This grant, with a funding amount of up to $275,000, is intended for short-term exploratory research projects (R21) that utilize comprehensive data collected from nearly 12,000 youth over several years, focusing on mental health, cognitive function, and various social influences. The initiative underscores the importance of innovative statistical methods and interdisciplinary collaboration, reflecting NIH's commitment to data-driven decisions in child health science. Interested applicants must submit their proposals by May 7, 2025, and can find further details and application guidelines at the NIH grants website or contact the NIH OER Webmaster at OERWebmaster03@od.nih.gov.
    Accelerating the Pace of Child Health Research Using Existing Data from the Adolescent Brain Cognitive Development (ABCD) Study (R01-Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) has announced a funding opportunity aimed at accelerating child health research through the analysis of existing data from the Adolescent Brain Cognitive Development (ABCD) Study. This initiative encourages researchers to utilize the extensive longitudinal dataset, which includes health, cognitive function, and environmental factors collected from nearly 12,000 youth starting at ages 9-10, to enhance understanding of adolescent health and development. The funding supports R01 grant applications without clinical trials, allowing for budgets of up to $250,000 annually for a maximum of five years, with applications due by May 7, 2025. Interested applicants can find more information and submission guidelines at the NIH website or contact the NIH OER Webmaster at OERWebmaster03@od.nih.gov.
    NIDA REI: Research on Neurocognitive Mechanisms Underlying the Impact of Structural Racism on the Substance Use Trajectory (R61/R33 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH), through the National Institute on Drug Abuse (NIDA), is offering a funding opportunity titled "Research on Neurocognitive Mechanisms Underlying the Impact of Structural Racism on the Substance Use Trajectory (R61/R33 Clinical Trial Optional)." This initiative aims to support exploratory and developmental research that investigates how structural racism influences substance use trajectories, with a focus on reducing the risk of substance use disorders and informing preventive strategies. The program encourages a multidisciplinary approach, integrating fields such as neuroscience, epidemiology, and sociology, while promoting community-engaged research methods to enhance racial equity. Interested applicants can apply for funding up to $500,000 for the initial R61 phase, with a total anticipated funding of $1.5 million annually for multiple awards. The application deadline is November 14, 2024, and further details can be found at the provided NIH link or by contacting the NIH OER Webmaster at OERWebmaster03@od.nih.gov.
    Accelerating the Pace of Drug Abuse Research Using Existing Data (R01 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "Accelerating the Pace of Drug Abuse Research Using Existing Data (R01 Clinical Trial Optional)" aimed at innovative analyses of existing datasets related to substance use behaviors and disorders. This initiative seeks to enhance understanding of the etiology and epidemiology of drug use, prevention strategies, and health service utilization by leveraging already available social science, neuroimaging, and administrative data, excluding primary data collection. The funding, with an anticipated commitment of $2 million for 3-5 awards, emphasizes compliance with ethical research practices and is open to a wide range of eligible applicants, including educational institutions and nonprofit organizations. Applications are due by November 15, 2024, and further details can be found at the provided link or by contacting the NIH OER Webmaster at OERWebmaster03@od.nih.gov.
    Combined Neuromodulation and Behavioral Treatment Algorithm Development for Stimulant Use Disorder (StUD) Enriched for Vulnerable Phenotype (U01 Clinical Trial Required)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH), through the National Institute on Drug Abuse (NIDA), has announced a funding opportunity titled "Combined Neuromodulation and Behavioral Treatment Algorithm Development for Stimulant Use Disorder (StUD) Enriched for Vulnerable Phenotype" (RFA-DA-25-057). This initiative aims to develop clinical trials that integrate non-invasive neuromodulation techniques, such as transcranial magnetic stimulation, with established behavioral therapies to address the high relapse rates and cognitive challenges faced by individuals with StUD. The funding opportunity is particularly significant as it seeks to fill the treatment gap for vulnerable populations exhibiting low executive function and impulsive traits, with a total funding amount of $2,000,000 anticipated to support three to five awards over a project period of up to five years. Interested applicants must submit their proposals by November 27, 2024, and can find additional details and application instructions at the NIH grants website or contact NIH Grants Information at grantsinfo@nih.gov.
    Mechanistic Research on Neuromodulation for Substance Use Disorders Treatment (R61/R33 Basic Experimental Studies with Humans Required)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) has announced a funding opportunity titled "Mechanistic Research on Neuromodulation for Substance Use Disorders Treatment," aimed at encouraging clinical research to explore novel non-invasive brain stimulation (NIBS) targets for treating substance use disorders (SUD). This initiative seeks applications for exploratory and developmental studies that will identify and validate neurobiological, cognitive, and behavioral responses to NIBS, with the goal of understanding mechanisms that could lead to reduced cravings and substance use. The NIH plans to allocate $1.5 million in funding for fiscal years 2024-2026, with an award ceiling of $500,000 per project phase, and key submission dates starting December 16, 2023. Interested applicants can find more information and guidelines at the NIH grants website or contact NIH Grants Information at grantsinfo@nih.gov for further inquiries.
    Translating Socioenvironmental Influences on Neurocognitive Development and Addiction Risk (TranSINDA) (U01 Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "Translating Socioenvironmental Influences on Neurocognitive Development and Addiction Risk" (TranSINDA), aimed at advancing research on the impact of early-life socioenvironmental factors on neurocognitive development and addiction risk. This initiative seeks applications for team-science research projects that utilize longitudinal research designs in animal models to elucidate mechanisms linking early social environments to substance use disorders (SUD) and their comorbidities. A total of $4 million is anticipated for FY 2025, with funding available for up to seven projects over a maximum period of five years. Interested applicants must submit their proposals by November 8, 2024, and can direct inquiries to NIH Grants Information at grantsinfo@nih.gov.
    Solutions to enable diagnosis and treatment of adverse health consequences of non-disordered drug use (R43/R44 - Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "Solutions to enable diagnosis and treatment of adverse health consequences of non-disordered drug use (R43/R44 - Clinical Trial Optional)" aimed at supporting Small Business Innovation Research (SBIR) proposals. This initiative seeks innovative, accessible, and affordable solutions to address health complications arising from non-disordered drug use, including issues such as hypoxia-related brain injuries from opioid overdoses and cardiovascular problems from stimulant use. The program anticipates a total budget of $2 million for approximately 2-5 awards in Fiscal Year 2025, with applications due by December 2, 2024. Interested applicants can find more information and guidelines at the NIH grants website or contact NIH Grants Information at grantsinfo@nih.gov for further inquiries.